First iPS Cell Trial for Heart Disease Raises Excitement, Concern

September 3, 2018

(The Scientist) – Early next year, a small clinical trial will begin in Japan, marking the first time reprogrammed stem cells will be deployed to help regenerate injured hearts. A team led by Osaka University cardiac surgeon Yoshiki Sawa will implant sheets—each consisting of 100 million stem-cell derived cardiomyocytes—onto the hearts of three patients with advanced heart failure.

Recommended Reading